Machine Learning

A new AI platform promises to fix billions in revenue loss from complex cardiac coding, but will it empower or replace human experts in the process?

A new peer-reviewed study shows Glucotrack's fully implantable glucose monitor is accurate for 240 days, a key step towards a 3-year, no-wearable future.

Hannover Re US names Kelly Rabin Chief Actuary, a strategic move leveraging her diverse insurtech and consulting background to drive innovation.

A new collaboration leverages a vast cord blood bank and advanced AI to create off-the-shelf cell therapies, promising a new era in regenerative medicine.

IEEE-USA is launching BiG Thinkers, a new event uniting leaders from Disney, OpenAI, and Pixar to cultivate creativity and leadership in tech professionals.

Documo’s award-winning AI platform is turning the tide on healthcare's reliance on fax, automating paperwork to reduce staff burnout and improve patient care.

Alkeus Pharmaceuticals will present crucial data on its oral drug for Stargardt disease, a leading cause of juvenile blindness with no current cure.

BsStrategy's latest platform update signals a major shift in AI finance, where robust infrastructure and risk control are eclipsing the hunt for magic algorithms.

With fresh capital, the Swedish biotech is scaling its revolutionary platform that decodes cellular communication, fueling a major US expansion.

A Boston biotech is using AI and targeted mRNA to program cells inside the body, aiming to make complex CAR T treatments safer and universally accessible.

A tiny brush, engineered to micron-level precision, is at the forefront of a high-tech shift in medical manufacturing, enabling the future of robotics and AI.

New pre-clinical data shows engineered immune cells (iMacrophages) can effectively target and destroy ovarian tumors, offering hope for a new treatment era.

A new IDEO report quantifies how specific workplace behaviors create a $10 billion profit gap, proving that how a company operates is its biggest asset.

Biotech firm Scribe Therapeutics, co-founded by a Nobel laureate, is pioneering a new gene therapy for high cholesterol that silences genes, not cuts them.

A new system from OSHIMA goes beyond simple defect detection, integrating AI inspection with spreading and cutting for a seamless smart factory workflow.

A new imaging agent could slash the years-long diagnostic delay for endometriosis, offering hope to millions of women suffering from the debilitating condition.

Swiss medtech firm CorFlow is tackling a major post-heart attack complication with two pivotal trials, aiming to create a new standard of care.

A new platform is launching AI-powered interviews and scheduling at a fraction of the cost of enterprise tools, promising to change how businesses hire.

New research challenges long-held beliefs, revealing a high-risk subset in "safe" tumors and a surprising link between body weight and cancer recurrence.

Jumio launches Watch, a continuous identity intelligence service to combat evolving risks like deepfakes and synthetic identities long after onboarding.